Drs Robert Glatter and Ken Milne discuss what the recent RSI trial reveals — and does not reveal — about choosing etomidate ...

The new model, called Scope AI, is addressing a very real problem: There aren't nearly enough doctors visiting encampments ...

Akido Labs, an LA-based health care technology company that runs clinics and street medicine teams in California, plans to ...

A MUM who has lost almost half her body weight thanks to Mounjaro has revealed the three mistakes new jabbers are making – ...

A California company is using AI to help diagnose homeless Californians. The technology promises better access to health care ...

Sacramento and Stanislaus counties are at a “higher risk,” while San Joaquin County is at a “very high risk,” the interactive map says.

The new model, called Scope AI, is addressing a very real problem: There aren’t nearly enough doctors visiting encampments ...

Sir Keir Starmer's January has been the stuff of nightmares.

Mid-stage trial data showed Roche's experimental shot delivered weight loss on par with leading obesity treatments, ...

The updated recommendations also address the link between high blood pressure and cognitive decline and dementia.

Here & Now’s Peter O’Dowd spoke with Sarah Zhang, a reporter for The Atlantic, about how people are searching the web and using the app Telegram to buy next-generation GLP-3 drugs not yet approved by ...

A drug Roche acquired in a multibillion-dollar deal could be as effective as Zepbound, but may struggle to stand out in a ...